Instil Bio

Update in progress

TIL (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Instil Bio, Inc. is a biopharmaceutical company focused on identifying, evaluating, and advancing therapeutic opportunities. The company seeks to in-license or acquire and develop novel therapeutic candidates targeting diseases with significant unmet medical need. Founded in 2018, Instil Bio is headquartered in Dallas, Texas.

Company score

Sentiment: -0.08; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.05; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.18; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.03; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive